Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:3
|
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Prevalence and clinical outcomes of COVID-19 in patients with pre-existing celiac disease: A systematic review and meta-analysis
    Rathore, Sawai Singh
    Velasquez-Botero, Felipe
    Nieto-Salazar, Maria Alejandra
    Flowers, Thomas C.
    Hasan, Jamal
    Parashar, Ashwani Kumar
    Tanveer, Khurram
    Aneis, Hamam
    Buremoh, Ayotunde Isaac
    Yusuf, Keturah
    Khalil, Khalil
    Toro-Velandia, Adriana Carolina
    Sabeeh, Shireen Kh.
    REVIEWS IN MEDICAL VIROLOGY, 2023, 33 (03)
  • [2] Coronary heart disease and COVID-19: A meta-analysis
    Liang, Chendi
    Zhang, Weijun
    Li, Shuzhen
    Qin, Gang
    MEDICINA CLINICA, 2021, 156 (11): : 547 - 554
  • [3] Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis
    Alzoughool, Foad
    Abumweis, Suhad
    Alanagreh, Lo'ai
    Atoum, Manar
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2022, 13 (01) : 37 - 50
  • [4] Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis
    Steinberg, Julia
    Hughes, Suzanne
    Hui, Harriet
    Allsop, Matthew J.
    Egger, Sam
    David, Michael
    Caruana, Michael
    Coxeter, Peter
    Carle, Chelsea
    Onyeka, Tonia
    Rewais, Isabel
    Monroy Iglesias, Maria J.
    Vives, Nuria
    Wei, Feixue
    Abila, Derrick Bary
    Carreras, Giulia
    Santero, Marilina
    O'Dowd, Emma L.
    Lui, Gigi
    Tolani, Musliu Adetola
    Mullooly, Maeve
    Lee, Shing Fung
    Landy, Rebecca
    Hanley, Sharon J. B.
    Binefa, Gemma
    Mcshane, Charlene M.
    Gizaw, Muluken
    Selvamuthu, Poongulali
    Boukheris, Houda
    Nakaganda, Annet
    Ergin, Isil
    Moraes, Fabio Ynoe
    Timilshina, Nahari
    Kumar, Ashutosh
    Vale, Diama B.
    Molina-Barcelo, Ana
    Force, Lisa M.
    Campbell, Denise Joan
    Wang, Yuqing
    Wan, Fang
    Baker, Anna-Lisa
    Singh, Ramnik
    Salam, Rehana Abdus
    Yuill, Susan
    Shah, Richa
    Lansdorp-Vogelaar, Iris
    Yusuf, Aasim
    Aggarwal, Ajay
    Murillo, Raul
    Torode, Julie S.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (08) : 1394 - 1412
  • [5] Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis
    Qian, Zhe
    Li, Zhuohong
    Peng, Jie
    Gao, Qiqing
    Cai, Shaohang
    Xu, Xuwen
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2022, 44 (05) : 451 - 458
  • [6] Prevalence of pre-existing peripheral artery disease in COVID-19 patients and relative mortality risk: Systematic review and meta-analysis
    Zuin, Marco
    Rigatelli, Gianluca
    Bilato, Marco J.
    Bilato, Claudio
    Roncon, Loris
    VASCULAR, 2023, 31 (06) : 1103 - 1109
  • [7] Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysis
    Ganesh, Adithan
    Randall, Michael D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2642 - 2656
  • [8] Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis
    Patel, Urvish
    Malik, Preeti
    Shah, Dhaivat
    Patel, Achint
    Dhamoon, Mandip
    Jani, Vishal
    JOURNAL OF NEUROLOGY, 2021, 268 (01) : 240 - 247
  • [9] COVID-19 and coronary artery disease; A systematic review and meta-analysis
    Hajikhani, Bahareh
    Safavi, Mahshid
    Bostanshirin, Nazila
    Sameni, Fatemeh
    Ghazi, Mona
    Yazdani, Shahrooz
    Nasiri, Mohammad Javad
    Khosravi-Dehaghi, Nafiseh
    Noorisepehr, Negin
    Sayyari, Saba
    Dadashi, Masoud
    NEW MICROBES AND NEW INFECTIONS, 2023, 53
  • [10] Cardiac biomarkers and COVID-19: A systematic review and meta-analysis
    An, Wen
    Kang, Ju-Seop
    Wang, Qiuyang
    Kim, Tae-Eun
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (09) : 1191 - 1197